# Clinical Research Malaysia

Source: https://onco.cc/institutions/clinical-research-malaysia/  
OnCo record `clinical-research-malaysia` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A research management organisation set up by Malaysia's Ministry of Health in 2012 to bring industry clinical trials to Malaysian hospitals and support the investigators who run them.

## Summary

Clinical Research Malaysia was established by the Ministry of Health in 2012 (company number 1006282-X) and describes itself as a research management organisation offering end-to-end support for clinical research, including feasibility studies and study coordinators. Its home page reports that it and AstraZeneca won the British Malaysian Chamber of Commerce's UK-Malaysia Partnership of the Year award in 2024 under a memorandum of understanding that included moving a clinical research management team to Malaysia and starting a first-in-human study, and that Roche chose Sarawak General Hospital as a site for a global first-in-human trial. It lists an office at KL Gateway, Jalan Kerinchi, Kuala Lumpur, and a new office in Penang.

Of the trials in OnCo's records, 171 list a site in Malaysia (ClinicalTrials.gov participation data, counted on 4 November 2026); AstraZeneca and Merck Sharp & Dohme lead the most. The coordinates are a Kuala Lumpur centroid.

## Fields

- Kind: Institution
- Last checked: 2026-11-04
- Also known as: CRM
- City: Kuala Lumpur, MY
- Type: government
- Website: https://clinicalresearch.my/

## Sources

- Clinical Research Malaysia: https://clinicalresearch.my/
- ClinicalTrials.gov: cancer studies with sites in Malaysia: https://clinicaltrials.gov/search?country=Malaysia&cond=Cancer

## Connected records

- institutions: [Institut Kanser Negara (National Cancer Institute, Malaysia)](https://onco.cc/institutions/institut-kanser-negara/), [Ministry of Health Malaysia](https://onco.cc/institutions/ministry-of-health-malaysia/), [National Pharmaceutical Regulatory Agency (NPRA), Malaysia](https://onco.cc/institutions/npra-malaysia/), [University of Malaya Medical Centre](https://onco.cc/institutions/ummc-kuala-lumpur/)
- trials: [FLAURA](https://onco.cc/trials/flaura/), [KEYNOTE-966](https://onco.cc/trials/keynote-966/), [Low Dose Nivolumab With Chemotherapy vs Standard Chemotherapy as First-Line Treatment in Advanced or Metastatic NSCLC](https://onco.cc/trials/nct07050043/)

---
JSON: https://onco.cc/api/v1/entities/clinical-research-malaysia.json